Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by inventorson Jun 18, 2014 11:51am
242 Views
Post# 22671184

Gap Up

Gap UpEarly birds gets the worms...lol.

One might be surprised to see the sp fill the $1.12 gap sooner rather than later...

It's just that Biotech Seasonality doesn't start until last week in June..

PLI should be at $1.60 now...$2.50 now, or real soon...and I'm fully expecting an intraday candle spike toping $3 by Sept....

This way it could retrace back down to $1.60 level before end of the year run, and surpass the $3 mark by Feb with a new all...time...high...
Bullboard Posts